Northwest Biotherapeutics, Inc.
Northwest Biotherapeutics, Inc. (Northwest) is a development stage biotechnology company engaged in the discovery, development and commercialization of immunotherapy products that generate and enhance immune system responses to treat cancer. The company based on its two basic technology platforms, dendritic cell-based cancer vaccines, called DCVax; and monoclonal antibodies for cancer therapeutics, has developed a robust pipeline of potent therapeutic product candidates. The company focuses in the therapeutic areas of oncology and immunology. The drug pipeline is been developed to treat the cancers related to brain, lung, liver, head and neck, pancreas, prostrate and ovarian. Northwest company is headquartered at Bothell in Washington, the US.